Gianluca Franceschini Selected Research

Gianluca Franceschini Research Topics

51	Breast Neoplasms (Breast Cancer) 11/2022 - 01/2006
21	Neoplasms (Cancer) 11/2022 - 03/2010
5	Margins of Excision 01/2020 - 01/2015
4	Neoplasm Metastasis (Metastasis) 06/2021 - 10/2003
3	Lymphedema (Milroy Disease) 12/2021 - 01/2020
3	Cicatrix (Scar) 10/2020 - 01/2019
2	Lobular Carcinoma 03/2022 - 01/2009
2	Disease Progression 01/2022 - 12/2021
2	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2021 - 05/2008
2	Necrosis 12/2020 - 11/2019
2	Ischemia 01/2020 - 01/2019
2	Pathologic Complete Response 01/2020 - 12/2016
2	Infections 11/2019 - 01/2019
1	Ductal Carcinoma 03/2022
1	Carcinoma in Situ 03/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Contracture 01/2021
1	COVID-19 01/2021
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 07/2020
1	Adult-Onset Still's Disease 07/2020
1	Heart Failure 07/2020
1	Seroma 01/2020
1	Pain (Aches) 08/2019
1	Wounds and Injuries (Trauma) 07/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Paresthesia (Dysesthesia) 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Residual Neoplasm 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2016
1	Inflammation (Inflammations) 09/2015
1	Fibrosis (Cirrhosis) 09/2015
1	Cardiotoxicity 01/2012
1	Adenoid Cystic Carcinoma (Cylindroma) 03/2010
1	Congenital Abnormalities (Deformity) 01/2009
1	Papillary Carcinoma 07/2006
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2004

5	purified rayonIBA 07/2019 - 01/2015
4	Hormones (Hormone)IBA 11/2022 - 09/2014
4	Biological ProductsIBA 06/2021 - 12/2017
3	Phenobarbital (Luminal)FDA Link 12/2021 - 09/2014
3	4-(2-oxapentadeca-4-yne)phenylpropanoic acidIBA 01/2016 - 01/2015
2	Pharmaceutical PreparationsIBA 01/2022 - 10/2021
2	Biomarkers (Surrogate Marker)IBA 08/2021 - 10/2004
2	palbociclibIBA 12/2020 - 01/2020
2	human ERBB2 proteinIBA 10/2015 - 09/2014
2	Docetaxel (Taxotere)FDA Link 10/2014 - 01/2012
2	AnthracyclinesIBA 10/2014 - 01/2012
1	Vitamin D FDA LinkGeneric 03/2022
1	hydroxide ionIBA 03/2022
1	Capecitabine (Xeloda)FDA Link 01/2022
1	pyrotinibIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 08/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 05/2021
1	apatinibIBA 05/2021
1	Fulvestrant (Faslodex)FDA Link 12/2020
1	Cyclin-Dependent Kinase 4IBA 12/2020
1	Everolimus FDA Link 12/2020
1	exemestane (Aromasin)FDA Link 12/2020
1	Oral ContraceptivesIBA 01/2020
1	SolutionsIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2019
1	Aromatase InhibitorsIBA 01/2019
1	PlasticsIBA 01/2019
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 09/2015
1	Capsules (Microcapsules)IBA 09/2015
1	liposomal doxorubicin (Doxil)FDA Link 01/2012

20	Mastectomy (Mammectomy) 12/2021 - 07/2006
16	Radiotherapy 01/2022 - 10/2004
12	Neoadjuvant Therapy 11/2022 - 10/2004
12	Segmental Mastectomy (Lumpectomy) 12/2021 - 01/2008
11	Therapeutics 12/2021 - 05/2008
10	Drug Therapy (Chemotherapy) 07/2021 - 10/2003
5	Mammaplasty (Breast Reconstruction) 01/2021 - 01/2016
3	Adjuvant Radiotherapy 07/2020 - 03/2010
2	Lymph Node Excision (Lymph Node Dissection) 12/2021 - 03/2016
2	Prophylactic Mastectomy 01/2020 - 01/2019
2	Contraindications 01/2020 - 01/2019
2	Tattooing 11/2019 - 01/2018
2	Radical Mastectomy 03/2015 - 01/2008
2	Conservative Treatment 03/2010 - 01/2006
1	Immunotherapy 06/2021
1	Preoperative Exercise 04/2021
1	Metastasectomy 03/2021
1	Breast Implants (Breast Implant) 10/2020
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2020
1	Operative Time 01/2020
1	Length of Stay 01/2020
1	Precision Medicine 07/2019
1	Salpingo-oophorectomy 01/2019
1	Chemoprevention 01/2019
1	Prostheses and Implants (Prosthesis) 01/2019
1	Adjuvant Chemotherapy 01/2018
1	Aftercare (After-Treatment) 03/2016